Hasnt Prevented Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hasnt prevented research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hasnt Prevented Research Today - Breaking & Trending Today

CNN CNN Saturday Morning May 18, 2013 12:27:00

Investment is paying off. its analysis tests cost up to $4,000, often covered by insurance and made up 82% of the company s revenue in fiscal 2012, the company s profit $112 million. biotech analyst steve brozak has followed myriad for another decade. are they going to stop researchers from using their work, no. the idea is someone else tries to do what they re doing commercially they have to be protected. reporter: myriad argues patenting genes encourages innovation and investment and hasn t prevented research. others disagree. we re at the cusp of the introduction of new technologies and certainly these patents can do nothing but obstruct the introduction of those technologies. reporter: now we should have a decision from the supreme court by the end of june. it s important to note here that experts say only 5% to 10% of women have this gene mutation, only 5% to 10%. ....

Analysis Tests , 12 Million , 112 Million , Steve Brozak , Hasnt Prevented Research , Gene Mutation , The End ,

CNN Erin Burnett OutFront May 17, 2013 03:21:00

Years in the project. that investment is paying off. the brock analysis test costs $4,000, often covered by insurance. and made up 82% of the company s revenue in fiscal 2012. the company s profit, $112 million. this biotech analyst has followed myriad for a decade. are they going to stop researchers from using their work? no. but the idea is if someone else tries to do what they re doing kplertially, they have to be protected. that s the critical difference. reporter: myriad argue that s patented genes encourages innovation and investment and hasn t prevented research. others disagree. we re at the cusp of the introduction of new technologies and certainly these patents can do nothing but obstruct the introduction of those technologies. it s amazing. you say $4,000. i know that may not be expensive to other tests, it seems that way to a lot of people. look, if they have a monopoly on a gene, then that s part of the reason why this is expensive and out of reach for some people. ....

Brock Analysis Test , Biotech Analyst , 12 Million , 112 Million , Hasnt Prevented Research ,

CNN Erin Burnett OutFront May 17, 2013 06:22:00

But the idea is if someone else tries to do what they re doing kplertially, they have to be protected. that s the critical difference. reporter: myriad argue that s patented genes encourages innovation and investment and hasn t prevented research. others disagree. wre at the cs and certainly these patents can do nothing but obstruct the introduction of those technologies. it s amazing. you say $4,000. i know that may not be expensive to other tests, it seems that way to a lot of people. look, if they have a monopoly on a gene, then that s part of the reason why this is expensive and out of reach for some people. how does it make sense? it s up to $4,000. it can be anywhere closer to $500. it depends how comprehensive of a test you get. and insurance, we found, covers this most of the time. the company also told me if people are not insured and they qualify for the test that they have reason to have it taken, then we will cover all of it or a great portion of it. but this really ....

Hasnt Prevented Research , Al L ,

CNN Erin Burnett OutFront May 16, 2013 23:25:00

That investment is paying off. the brock analysis test costs $4,000, often covered by insurance. and made up 82% of the company s revenue in fiscal 2012. the company s profit, $112 million. this biotech analyst has followed myriad for a decade. are they going to stop researchers from using their work? no. but the idea is if someone else tries to do what they re doing kplertially, they have to be protected. that s the critical difference. reporter: myriad argue that s patented genes encourages innovation and investment and hasn t prevented research. others disagree. we re at the cusp of the introduction of new technologies and certainly these patents can do nothing but obstruct the introduction of those technologies. it s amazing. you say $4,000. i know that may not be expensive to other tests, it seems that way to a lot of people. look, if they have a monopoly on a gene, then that s part of the ....

Brock Analysis Test , 112 Million , 12 Million , Biotech Analyst , Hasnt Prevented Research ,